capivasertib

Italy

Drugs containing this active substance

  • TRUQAP

    TRUQAP is used in combination with fulvestrant to treat adult patients with estrogen receptor (ER)-positive, HER2-negative advanced or metastatic breast cancer that presents abnormalities in one or more specific genes (PIK3CA, AKT1, or PTEN) and which does not respond to hormonal therapy.

    Form: tablets, film-coated

    Active substance Dosage
    capivasertib -

    ATC: L01EX27

    Manufacturer: ASTRAZENECA AB